Advertisement
Advertisement

APGE

APGE logo

Apogee Therapeutics, Inc. Common Stock

81.16
USD
Sponsored
-1.27
-1.54%
May 22, 16:00 UTC -4
Closed
exchange

After-Market

81.12

-0.04
-0.05%

Apogee Therapeutics, Inc. Common Stock Profile

About

Apogee Therapeutics LLC is a biotechnology company advancing novel, potentially therapies to address the needs of the millions of people living with immunological and inflammatory disorders. Apogee Therapeutics LLC is based in SAN FRANCISCO.

Info & Links

CEO

Michael Henderson

Headquarters

221 CRESCENT ST.,BUILDING 17, SUITE 102B
WALTHAM, MA 02453, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.apogeetherapeutics.com

Auditor

Ernst & Young LLP

Share holders

6

Employees

261

Apogee Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.12B

Enterprise Value

5.66B

Enterprise Value/EBITDA(ttm)

-18.25

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

6.54

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-36.77%

Return on Invested Capital(ttm)

-37.66%

Return on Assets(ttm)

-34.87%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-310.32M

Net Income Available to Common(ttm)

-274.62M

Diluted EPS(ttm)

-4.22

Share Statistics

Beta (5Y Monthly)

1.02

52-Week Change

105.57%

S&P 500 52-Week Change

26.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

75.39M

Dividend Yield

0.00%

Float4

39.77M

% Held by Insiders

42.77%

% Held by Institutions

79.04%

Balance Sheet

Total Cash(mrq)

1.06B

Total Cash Per Share(mrq)

14.06

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

26.57%

Quick Ratio(mrq)

26.57%

Book Value Per Share(mrq)

13.21

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.75

Free Cash Flow(ytd)

-232.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement